Intellia Therapeutics, Inc. (NTLA) NASDAQ

10.46

+0.84(+8.73%)

Updated at February 05 03:40PM

Currency In USD

Valuation

Market Cap2.71B
Enterprise Value2.6B
P/E Ratio-2.02
PEG Ratio-2.77
Price/Sales Ratio24.73
Price/Book Ratio1.1
Enterprise/Revenue24.29
Enterprise/EBITDA-1.98

Fiscal Year

Fiscal YearDecember 31, 2023
Most Recent QuarterSeptember 30, 2024

Profitability

Profit Margin-12.12
Operating Margin-12.48

Management Effectiveness

Return On Assets-0.45
Return On Equity-0.52

Income Statement

Revenue36.28M
Revenue/Share0.43
Gross Profit27.3M
EBITDA-506.32M
Net Income-481.19M
Diluted EPS-5.42

Balance Sheet

Total Cash658.11M
Total Cash/Share6.52
Total Debt101.62M
Total Debt/Equity0.11
Current Ratio6.73
Book Value Per Share9.53

Price History

52-Week Change-57.89
52-Week High34.87
52-Week Low9.25
Moving Average 50 Days12.35
Moving Average 200 Days19.51

Statistics

Average Volume2.82M
Shares Outstanding101.85M
% Held by Institutions92.23

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A